A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery
Monday, June 18, 2018
In my preview ahead of London Calling, I suggested that VolTRAX is a device that still hasn't found its raison d'etre. With the meeting, the device officially pre-launched and the company is now taking pre-orders for delivery in the Fall. And it still feels like a device which hasn't yet found its purpose, though Clive Brown presented a dazzling (if perhaps distant) vision of where VolTRAX might go.
Wednesday, June 13, 2018
LC2018: Flongle, Ubik-a-something and Metricoin
London Calling has been over for nearly three weeks. I originally wanted to write up at least something after the first night, but fatigue overcame me and I didn't get anything useful put together. And then travel and more fatigue set in. But beyond that and the usual temptation to procrastinate, there is the challenge of forming a coherent narrative from all the different threads at the meeting. There's all the Oxford Nanopore official announcements and then various user presentation tidbits. After several failed mental attempts to compose a big picture take on everything, I've decided to try to write a series (number yet indeterminate) of posts that will focus of various axes of the meeting. Hopefully they won't be to redundant -- or self-contradictory -- and that by following one particular thread I can actually condense some coherent thoughts. This first such thread starts with Flongle.
Subscribe to: Posts (Atom)